Pub Date : 2025-12-01Epub Date: 2025-07-18DOI: 10.1002/mdc3.70237
María Rivera-Sánchez, Antonio Sánchez-Rodríguez, Leire Manrique, María Sierra, Isabel González-Aramburu, María Victoria Sánchez-Peláez, Marián Martínez, Anjana López-Delgado, Jon Infante
{"title":"The Benefit of Exclusive Nocturnal Levodopa-Carbidopa Intestinal Infusion for Severe Refractory Sleep Behavior Disorder in Parkinson's Disease.","authors":"María Rivera-Sánchez, Antonio Sánchez-Rodríguez, Leire Manrique, María Sierra, Isabel González-Aramburu, María Victoria Sánchez-Peláez, Marián Martínez, Anjana López-Delgado, Jon Infante","doi":"10.1002/mdc3.70237","DOIUrl":"10.1002/mdc3.70237","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2379-2381"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715335/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144659684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-07-22DOI: 10.1002/mdc3.70255
Daniel G Di Luca, Ali Shalash
{"title":"Addressing Variability and Bridging the Gap in Parkinson's Disease Care: A Call to Action.","authors":"Daniel G Di Luca, Ali Shalash","doi":"10.1002/mdc3.70255","DOIUrl":"10.1002/mdc3.70255","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2055-2057"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715327/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144691040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-08-25DOI: 10.1002/mdc3.70303
Rosanna Varden, Ailish O'Callaghan, Richard Walker
Background: Globally the prevalence of Idiopathic Parkinson's Disease (IPD) is rising. Increasing recognition is being given to the influence of environmental factors on this rise, although the precise impact of such factors remains poorly understood. We need accurate ways of measuring prevalence to understand regional and global trends.
Objectives: To use case finding methodology to measure the crude, and age adjusted, prevalence of IPD in a rural area of North West England, and to describe the difference in results with those obtained using electronic record searching alone to understand the accuracy of such methods. To compare prevalence between subgroups to build hypotheses that could guide further research.
Methods: Local Parkinson's service records from several sources were searched electronically and manually reviewed against validated diagnostic criteria. Figures were age adjusted according to the national denominator population.
Results: The age adjusted prevalence of IPD was 201/100,000 (95% CI 186-217), higher than in any other published UK study using similar case finding methods. Numbers were higher using electronic diagnostic code searching alone, which may over estimate prevalence. No significant difference was seen between rural and urban areas, relative risk 0.92 (95% CI 0.80-1.06), although there was a trend to higher prevalence in historically industrial coastal areas.
Conclusions: This study highlights some of the pitfalls in using large healthcare datasets to measure IPD prevalence. Overall, the prevalence of IPD is high in this predominantly rural area, and exhibits prevalence trends that warrant further investigation in relation to genetic and environmental factors.
背景:全球特发性帕金森病(IPD)的患病率正在上升。人们日益认识到环境因素对这种上升的影响,尽管对这些因素的确切影响仍然知之甚少。我们需要准确的衡量流行率的方法,以了解区域和全球趋势。目的:使用病例查找方法测量英格兰西北部农村地区的原始和年龄调整后的IPD患病率,并描述结果与单独使用电子记录检索获得的结果的差异,以了解此类方法的准确性。比较亚组之间的患病率,以建立可以指导进一步研究的假设。方法:以电子方式检索来自多个来源的本地帕金森服务记录,并根据验证的诊断标准进行人工审查。数据根据全国分母人口进行年龄调整。结果:经年龄调整的IPD患病率为201/100,000 (95% CI 186-217),高于使用类似病例查找方法的任何其他已发表的英国研究。单独使用电子诊断代码搜索的数字更高,这可能高估了患病率。农村和城市地区之间没有显著差异,相对危险度为0.92 (95% CI 0.80-1.06),尽管在历史上的工业沿海地区有较高流行率的趋势。结论:本研究强调了使用大型医疗数据集测量IPD患病率的一些缺陷。总的来说,IPD的患病率在这个主要是农村地区很高,并且显示出与遗传和环境因素有关的进一步调查的流行趋势。
{"title":"An Exploration of the High Prevalence of Parkinson's Disease in a Rural Area of North West England.","authors":"Rosanna Varden, Ailish O'Callaghan, Richard Walker","doi":"10.1002/mdc3.70303","DOIUrl":"10.1002/mdc3.70303","url":null,"abstract":"<p><strong>Background: </strong>Globally the prevalence of Idiopathic Parkinson's Disease (IPD) is rising. Increasing recognition is being given to the influence of environmental factors on this rise, although the precise impact of such factors remains poorly understood. We need accurate ways of measuring prevalence to understand regional and global trends.</p><p><strong>Objectives: </strong>To use case finding methodology to measure the crude, and age adjusted, prevalence of IPD in a rural area of North West England, and to describe the difference in results with those obtained using electronic record searching alone to understand the accuracy of such methods. To compare prevalence between subgroups to build hypotheses that could guide further research.</p><p><strong>Methods: </strong>Local Parkinson's service records from several sources were searched electronically and manually reviewed against validated diagnostic criteria. Figures were age adjusted according to the national denominator population.</p><p><strong>Results: </strong>The age adjusted prevalence of IPD was 201/100,000 (95% CI 186-217), higher than in any other published UK study using similar case finding methods. Numbers were higher using electronic diagnostic code searching alone, which may over estimate prevalence. No significant difference was seen between rural and urban areas, relative risk 0.92 (95% CI 0.80-1.06), although there was a trend to higher prevalence in historically industrial coastal areas.</p><p><strong>Conclusions: </strong>This study highlights some of the pitfalls in using large healthcare datasets to measure IPD prevalence. Overall, the prevalence of IPD is high in this predominantly rural area, and exhibits prevalence trends that warrant further investigation in relation to genetic and environmental factors.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2304-2310"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144962076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-07-22DOI: 10.1002/mdc3.70244
Sergio A Castillo-Torres, Ivonne Cruz, Malco Rossi, Miguel Wilken, Daniel Cerquetti, Marcelo Merello
Background: MDS-UPDRS Severity Levels (SLs), derived from clinician- and patient-rated scales, remain underused to evaluate response to subthalamic deep brain stimulation (STN-DBS) in patients with Parkinson's disease (PD).
Objectives: To evaluate MDS-UPDRS SL as markers of STN-DBS response.
Methods: SLs were categorized as mild, moderate, or severe using established cut-off points for Parts II, III Off, and IV. Improvement was defined as a decrease in at least one SL. Part III Off improvement was correlated to quality-of-life scales and used to predict SL improvement using ROC Curve analysis.
Results: A total of 51 patients (34.1% female, aged 58.9 ± 10.2 years, disease duration 12.3 ± 4.1 years) were evaluated 12 months after surgery. MDS-UPDRS III Off changes over 30% predicted SL improvements in MDS-UPDRS II (AUC = 0.83, p = 0.015) and IV (AUC = 0.89, p = 0.001).
Conclusion: Our findings suggest that improvement in MDS-UPDRS SL are potential markers of STN-DBS response. With an MDS-UPDRS part III improvement around 30% predicting SL improvement.
背景:MDS-UPDRS严重程度等级(SLs)来源于临床医生和患者评分的量表,但仍未充分用于评估帕金森病(PD)患者对丘脑下深部脑刺激(STN-DBS)的反应。目的:评价MDS-UPDRS SL作为STN-DBS反应的标志物。方法:使用第二部分、第三部分和第四部分的既定截止点将SL分为轻度、中度或重度。改善被定义为至少一种SL的减少。第三部分的改善与生活质量量表相关,并使用ROC曲线分析用于预测SL的改善。结果:术后12个月评估51例患者(女性34.1%,年龄58.9±10.2岁,病程12.3±4.1年)。MDS-UPDRS III的Off变化超过30%预示着MDS-UPDRS II (AUC = 0.83, p = 0.015)和IV (AUC = 0.89, p = 0.001)的SL改善。结论:我们的研究结果表明MDS-UPDRS SL的改善是STN-DBS反应的潜在标志。随着MDS-UPDRS第三部分的改进,大约30%的预测SL改善。
{"title":"Analysis of DBS Outcome by MDS-UPDRS Severity Levels: Comparison with Changes on MDS-UPDRS III.","authors":"Sergio A Castillo-Torres, Ivonne Cruz, Malco Rossi, Miguel Wilken, Daniel Cerquetti, Marcelo Merello","doi":"10.1002/mdc3.70244","DOIUrl":"10.1002/mdc3.70244","url":null,"abstract":"<p><strong>Background: </strong>MDS-UPDRS Severity Levels (SLs), derived from clinician- and patient-rated scales, remain underused to evaluate response to subthalamic deep brain stimulation (STN-DBS) in patients with Parkinson's disease (PD).</p><p><strong>Objectives: </strong>To evaluate MDS-UPDRS SL as markers of STN-DBS response.</p><p><strong>Methods: </strong>SLs were categorized as mild, moderate, or severe using established cut-off points for Parts II, III Off, and IV. Improvement was defined as a decrease in at least one SL. Part III Off improvement was correlated to quality-of-life scales and used to predict SL improvement using ROC Curve analysis.</p><p><strong>Results: </strong>A total of 51 patients (34.1% female, aged 58.9 ± 10.2 years, disease duration 12.3 ± 4.1 years) were evaluated 12 months after surgery. MDS-UPDRS III Off changes over 30% predicted SL improvements in MDS-UPDRS II (AUC = 0.83, p = 0.015) and IV (AUC = 0.89, p = 0.001).</p><p><strong>Conclusion: </strong>Our findings suggest that improvement in MDS-UPDRS SL are potential markers of STN-DBS response. With an MDS-UPDRS part III improvement around 30% predicting SL improvement.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2324-2329"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144962029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-08-14DOI: 10.1002/mdc3.70274
Artur Vetkas, Andrew Yang, Alexandre Boutet, Cletus Cheyuo, Brendan Santyr, Can Sarica, Benjamin Davidson, Anton Fomenko, Nardin Samuel, Stefan Lang, Srdjan Sumarac, Luka Milosevic, Taufik Valiante, Mojgan Hodaie, Suneil K Kalia, Andres M Lozano
Background: Deep brain stimulation (DBS) is an established treatment for movement disorders such as Parkinson's disease (PD) and essential tremor (ET). However, the decision between unilateral, staged bilateral, or simultaneous bilateral DBS remains controversial, influenced by clinical presentation, patient preferences, and economic factors.
Objective: The aim was to compare motor score improvements, adverse events (AE), incremental benefits, and progression with unilateral to bilateral procedures and the rationale for second-side surgery.
Methods: This systematic review examined studies on patients treated with unilateral or bilateral (simultaneous or staged) DBS from 1999 to 2025, focusing on outcomes, safety, and efficacy.
Results: In PD, unilateral DBS targeting the subthalamic nucleus (STN) or globus pallidus internus (GPi) improves motor scores by up to 37%, whereas bilateral DBS yields improvements of up to 66%. Unilateral DBS provides up to 75% improvement in contralateral symptoms but only up to 28% in ipsilateral symptoms. More than half of PD patients eventually opt for second-side surgery due to worsening symptoms. In ET, unilateral ventral intermediate nucleus (VIM) DBS improves hand tremor by up to 89%, with staged bilateral procedures offering an additional 77% to 89% improvement contralaterally. Axial tremor improves by up to 60% with unilateral VIM DBS and a further 60% after bilateral surgery. Bilateral VIM DBS is linked to more AEs, such as gait disorders and dysarthria, whereas STN and GPi DBS have comparable risks. Staged surgeries are associated with longer surgical times and increased revisions and programming.
Conclusions: Individualized treatment decisions are essential, with bilateral DBS providing superior long-term outcomes for both PD and ET.
{"title":"One Side or Two? A Systematic Review of Deep Brain Stimulation Approaches in Movement Disorders.","authors":"Artur Vetkas, Andrew Yang, Alexandre Boutet, Cletus Cheyuo, Brendan Santyr, Can Sarica, Benjamin Davidson, Anton Fomenko, Nardin Samuel, Stefan Lang, Srdjan Sumarac, Luka Milosevic, Taufik Valiante, Mojgan Hodaie, Suneil K Kalia, Andres M Lozano","doi":"10.1002/mdc3.70274","DOIUrl":"10.1002/mdc3.70274","url":null,"abstract":"<p><strong>Background: </strong>Deep brain stimulation (DBS) is an established treatment for movement disorders such as Parkinson's disease (PD) and essential tremor (ET). However, the decision between unilateral, staged bilateral, or simultaneous bilateral DBS remains controversial, influenced by clinical presentation, patient preferences, and economic factors.</p><p><strong>Objective: </strong>The aim was to compare motor score improvements, adverse events (AE), incremental benefits, and progression with unilateral to bilateral procedures and the rationale for second-side surgery.</p><p><strong>Methods: </strong>This systematic review examined studies on patients treated with unilateral or bilateral (simultaneous or staged) DBS from 1999 to 2025, focusing on outcomes, safety, and efficacy.</p><p><strong>Results: </strong>In PD, unilateral DBS targeting the subthalamic nucleus (STN) or globus pallidus internus (GPi) improves motor scores by up to 37%, whereas bilateral DBS yields improvements of up to 66%. Unilateral DBS provides up to 75% improvement in contralateral symptoms but only up to 28% in ipsilateral symptoms. More than half of PD patients eventually opt for second-side surgery due to worsening symptoms. In ET, unilateral ventral intermediate nucleus (VIM) DBS improves hand tremor by up to 89%, with staged bilateral procedures offering an additional 77% to 89% improvement contralaterally. Axial tremor improves by up to 60% with unilateral VIM DBS and a further 60% after bilateral surgery. Bilateral VIM DBS is linked to more AEs, such as gait disorders and dysarthria, whereas STN and GPi DBS have comparable risks. Staged surgeries are associated with longer surgical times and increased revisions and programming.</p><p><strong>Conclusions: </strong>Individualized treatment decisions are essential, with bilateral DBS providing superior long-term outcomes for both PD and ET.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2080-2091"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715356/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144855865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-07-11DOI: 10.1002/mdc3.70235
Sepehr Khosravi, Gholamali Shahidi, Anthony E Lang, Mohammad Rohani
{"title":"Various Gait Patterns in Chorea-Acanthocytosis.","authors":"Sepehr Khosravi, Gholamali Shahidi, Anthony E Lang, Mohammad Rohani","doi":"10.1002/mdc3.70235","DOIUrl":"10.1002/mdc3.70235","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2366-2367"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144619157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-07-14DOI: 10.1002/mdc3.70225
Clara Rentz, Alisha Reinhardt, Naomi Jung, Vignesh Vanchinathan, Jutta Peterburs, Heike Jacobi, Dagmar Timmann, Andreas Thieme, Doris Brötz, Christian Bellebaum, Alfons Schnitzler, Katrin Amunts, Martina Minnerop
Background: Gait and balance impairment is a disabling clinical feature in people with degenerative cerebellar ataxia.
Objectives: We performed a rater-blinded, parallel 3-arm randomized controlled trial with delayed-start-design (exploratory proof-of-concept study) to assess whether, compared to control, people with mild/moderate hereditary ataxia benefit from additional video-based training with different frequencies, and how clinical characteristics interact with training success.
Methods: Digital gait/balance measures were assessed before and after a three-week video-based training program at home (Train20: 4 × 20min/week, n = 11; Train40: 2 × 40min/week, n = 11; control: standard medical care, n = 10). Group differences at baseline and changes over time were assessed using ANOVA. Linear mixed models were conducted to examine the influence of clinical variables on outcomes over time. Further exploratory analyses were performed using intraclass correlation coefficients (ICC), and paired t-tests within each group.
Results: All variables showed good to excellent test-retest reliability (ICC ≥0.69). No significant interactions between group and measurement time were found for clinical or gait/balance variables (p ≥ 0.338). However, participants with higher initial disease severity, greater impairment in activities of daily living, and better well-being showed significant improvements in feet-together stance (p = 0.04), normal (p = 0.01), and backward gait (p = 0.03). Exploratory analyses showed improvement only in Train40.
Conclusions: Although the protocol did not lead to general improvements in people with mild/moderate ataxia, irrespective of training frequency, those with higher initial disease severity, higher functional impairment, and better mental well-being showed significant benefits. Greater attention should be given to the impact of well-being to enhance motor training outcomes. Longer, less frequent sessions may offer greater potential for improvement.
{"title":"Three-Week Video- and Home-Based Training Program for People with Ataxia: A Pilot Randomized Controlled Trial.","authors":"Clara Rentz, Alisha Reinhardt, Naomi Jung, Vignesh Vanchinathan, Jutta Peterburs, Heike Jacobi, Dagmar Timmann, Andreas Thieme, Doris Brötz, Christian Bellebaum, Alfons Schnitzler, Katrin Amunts, Martina Minnerop","doi":"10.1002/mdc3.70225","DOIUrl":"10.1002/mdc3.70225","url":null,"abstract":"<p><strong>Background: </strong>Gait and balance impairment is a disabling clinical feature in people with degenerative cerebellar ataxia.</p><p><strong>Objectives: </strong>We performed a rater-blinded, parallel 3-arm randomized controlled trial with delayed-start-design (exploratory proof-of-concept study) to assess whether, compared to control, people with mild/moderate hereditary ataxia benefit from additional video-based training with different frequencies, and how clinical characteristics interact with training success.</p><p><strong>Methods: </strong>Digital gait/balance measures were assessed before and after a three-week video-based training program at home (Train20: 4 × 20min/week, n = 11; Train40: 2 × 40min/week, n = 11; control: standard medical care, n = 10). Group differences at baseline and changes over time were assessed using ANOVA. Linear mixed models were conducted to examine the influence of clinical variables on outcomes over time. Further exploratory analyses were performed using intraclass correlation coefficients (ICC), and paired t-tests within each group.</p><p><strong>Results: </strong>All variables showed good to excellent test-retest reliability (ICC ≥0.69). No significant interactions between group and measurement time were found for clinical or gait/balance variables (p ≥ 0.338). However, participants with higher initial disease severity, greater impairment in activities of daily living, and better well-being showed significant improvements in feet-together stance (p = 0.04), normal (p = 0.01), and backward gait (p = 0.03). Exploratory analyses showed improvement only in Train40.</p><p><strong>Conclusions: </strong>Although the protocol did not lead to general improvements in people with mild/moderate ataxia, irrespective of training frequency, those with higher initial disease severity, higher functional impairment, and better mental well-being showed significant benefits. Greater attention should be given to the impact of well-being to enhance motor training outcomes. Longer, less frequent sessions may offer greater potential for improvement.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2154-2167"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715367/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144626759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-06-28DOI: 10.1002/mdc3.70197
Charles Palmer, Alexander McClanahan, Federico Rodriguez-Porcel
{"title":"Discontinuation of the Clozapine Risk Evaluation and Mitigation Strategy and Implications in Movement Disorders.","authors":"Charles Palmer, Alexander McClanahan, Federico Rodriguez-Porcel","doi":"10.1002/mdc3.70197","DOIUrl":"10.1002/mdc3.70197","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2106-2110"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715328/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144529013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Impulsive-compulsive behavior disorders (ICBDs) in Parkinson's disease (PD) include impulse control disorders (ICDs) and compulsive behaviors, often linked to dopaminergic treatment and altered reward processing. Interoception, the perception of internal bodily signals, plays a key role in emotional regulation and decision-making. Neuroimaging studies suggest that alterations in interoceptive and reward-related brain circuits may underlie ICDs in PD. However, the relationship between interoception and ICDs remains underexplored.
Objective: To investigate the relationship between impulse control disorders (ICD) severity and interoceptive abilities-specifically interoceptive accuracy, insight, and self-reported interoception-in PD patients.
Methods: Fifty-one participants were assessed using the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease Rating Scale (QUIP-RS) alongside measures of interoceptive performance, anxiety, depression, and apathy.
Results: Higher ICD severity predicted increased interoceptive insight and sensibility. No significant link was found between ICD severity and interoceptive accuracy. Additionally, higher Levodopa Equivalent Daily Dose (LEDD) was related to lower interoceptive insight, suggesting a potential modulatory effect of dopaminergic therapy on meta-cognitive interoception.
Conclusions: These findings highlight the complex interplay between ICDs and interoception, suggesting that heightened self-reported interoception and interoceptive insight may reinforce impulsive behaviors in PD via enhanced bodily signal salience. This study contributes to understanding the characteristics of ICDs in PD, implicating reward-related circuits such as the insula and anterior cingulate cortex.
{"title":"From Inner Sense to Outer Action: Interoception and Impulsive Compulsive Behavior Disorders in Parkinson's Disease.","authors":"Chiara Baiano, Francesca Morgante, Diana Goeta, Chiara Giacobbe, Marianna Amboni, Carmine Vitale, Elena Makovac, Benedetta Demartini, Gabriella Santangelo, Lucia Ricciardi","doi":"10.1002/mdc3.70187","DOIUrl":"10.1002/mdc3.70187","url":null,"abstract":"<p><strong>Background: </strong>Impulsive-compulsive behavior disorders (ICBDs) in Parkinson's disease (PD) include impulse control disorders (ICDs) and compulsive behaviors, often linked to dopaminergic treatment and altered reward processing. Interoception, the perception of internal bodily signals, plays a key role in emotional regulation and decision-making. Neuroimaging studies suggest that alterations in interoceptive and reward-related brain circuits may underlie ICDs in PD. However, the relationship between interoception and ICDs remains underexplored.</p><p><strong>Objective: </strong>To investigate the relationship between impulse control disorders (ICD) severity and interoceptive abilities-specifically interoceptive accuracy, insight, and self-reported interoception-in PD patients.</p><p><strong>Methods: </strong>Fifty-one participants were assessed using the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease Rating Scale (QUIP-RS) alongside measures of interoceptive performance, anxiety, depression, and apathy.</p><p><strong>Results: </strong>Higher ICD severity predicted increased interoceptive insight and sensibility. No significant link was found between ICD severity and interoceptive accuracy. Additionally, higher Levodopa Equivalent Daily Dose (LEDD) was related to lower interoceptive insight, suggesting a potential modulatory effect of dopaminergic therapy on meta-cognitive interoception.</p><p><strong>Conclusions: </strong>These findings highlight the complex interplay between ICDs and interoception, suggesting that heightened self-reported interoception and interoceptive insight may reinforce impulsive behaviors in PD via enhanced bodily signal salience. This study contributes to understanding the characteristics of ICDs in PD, implicating reward-related circuits such as the insula and anterior cingulate cortex.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2253-2259"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144369091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}